Annual Working Capital
$3.50 M
-$9.93 M-73.91%
December 31, 2023
Summary
- As of February 8, 2025, OCX annual working capital is $3.50 million, with the most recent change of -$9.93 million (-73.91%) on December 31, 2023.
- During the last 3 years, OCX annual working capital has risen by +$3.27 million (+1423.48%).
- OCX annual working capital is now -86.00% below its all-time high of $25.02 million, reached on December 31, 2021.
Performance
OCX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$4.30 M
-$7.07 M-255.13%
September 30, 2024
Summary
- As of February 8, 2025, OCX quarterly working capital is -$4.30 million, with the most recent change of -$7.07 million (-255.13%) on September 30, 2024.
- Over the past year, OCX quarterly working capital has dropped by -$13.18 million (-148.37%).
- OCX quarterly working capital is now -108.09% below its all-time high of $53.14 million, reached on March 31, 2021.
Performance
OCX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
OCX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -73.9% | -148.4% |
| 3 y3 years | +1423.5% | -112.2% |
| 5 y5 years | +13.7% | -112.2% |
OCX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.0% | at low | -112.2% | at low |
| 5 y | 5-year | -86.0% | +1423.5% | -108.1% | at low |
| alltime | all time | -86.0% | +231.5% | -108.1% | at low |
OncoCyte Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$4.30 M(-255.1%) |
| Jun 2024 | - | $2.77 M(-254.6%) |
| Mar 2024 | - | -$1.79 M(-151.1%) |
| Dec 2023 | $3.50 M(-73.9%) | $3.50 M(-60.6%) |
| Sep 2023 | - | $8.88 M(-33.3%) |
| Jun 2023 | - | $13.32 M(+114.2%) |
| Mar 2023 | - | $6.22 M(-53.7%) |
| Dec 2022 | $13.43 M(-46.3%) | $13.43 M(-43.3%) |
| Sep 2022 | - | $23.68 M(-32.7%) |
| Jun 2022 | - | $35.21 M(+230.1%) |
| Mar 2022 | - | $10.67 M(-57.4%) |
| Dec 2021 | $25.02 M(>+9900.0%) | $25.02 M(-26.9%) |
| Sep 2021 | - | $34.21 M(+13.2%) |
| Jun 2021 | - | $30.22 M(-43.1%) |
| Mar 2021 | - | $53.14 M(>+9900.0%) |
| Dec 2020 | $230.00 K(-98.8%) | $230.00 K(-92.5%) |
| Sep 2020 | - | $3.08 M(-73.5%) |
| Jun 2020 | - | $11.60 M(+3.5%) |
| Mar 2020 | - | $11.21 M(-39.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $18.52 M(+501.0%) | $18.52 M(+7.4%) |
| Sep 2019 | - | $17.23 M(-47.8%) |
| Jun 2019 | - | $33.00 M(-12.7%) |
| Mar 2019 | - | $37.80 M(+1126.7%) |
| Dec 2018 | $3.08 M(-24.4%) | $3.08 M(-57.7%) |
| Sep 2018 | - | $7.28 M(+5.2%) |
| Jun 2018 | - | $6.92 M(-19.4%) |
| Mar 2018 | - | $8.59 M(+110.8%) |
| Dec 2017 | $4.07 M(-51.6%) | $4.07 M(-48.1%) |
| Sep 2017 | - | $7.85 M(+40.6%) |
| Jun 2017 | - | $5.58 M(-37.3%) |
| Mar 2017 | - | $8.90 M(+5.7%) |
| Dec 2016 | $8.42 M(-2.2%) | $8.42 M(-25.6%) |
| Sep 2016 | - | $11.31 M(+273.0%) |
| Jun 2016 | - | $3.03 M(-41.0%) |
| Mar 2016 | - | $5.14 M(-40.3%) |
| Dec 2015 | $8.61 M(-423.2%) | $8.61 M(-13.6%) |
| Sep 2015 | - | $9.97 M(-474.3%) |
| Dec 2014 | -$2.66 M(-1588.3%) | -$2.66 M |
| Dec 2013 | $179.00 K | - |
FAQ
- What is OncoCyte annual working capital?
- What is the all time high annual working capital for OncoCyte?
- What is OncoCyte annual working capital year-on-year change?
- What is OncoCyte quarterly working capital?
- What is the all time high quarterly working capital for OncoCyte?
- What is OncoCyte quarterly working capital year-on-year change?
What is OncoCyte annual working capital?
The current annual working capital of OCX is $3.50 M
What is the all time high annual working capital for OncoCyte?
OncoCyte all-time high annual working capital is $25.02 M
What is OncoCyte annual working capital year-on-year change?
Over the past year, OCX annual working capital has changed by -$9.93 M (-73.91%)
What is OncoCyte quarterly working capital?
The current quarterly working capital of OCX is -$4.30 M
What is the all time high quarterly working capital for OncoCyte?
OncoCyte all-time high quarterly working capital is $53.14 M
What is OncoCyte quarterly working capital year-on-year change?
Over the past year, OCX quarterly working capital has changed by -$13.18 M (-148.37%)